These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1091001)

  • 1. Colestipol hydrochloride, a new hypolipidemic drug: a two-year study.
    Cooper EE; Michel AM
    South Med J; 1975 Mar; 68(3):303-9. PubMed ID: 1091001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term cholesterol-lowering effect of colestipol resin in humans.
    Gross L; Figueredo R
    J Am Geriatr Soc; 1973 Dec; 21(12):552-6. PubMed ID: 4584170
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term treatment of hypercholesterolemia with colestipol hydrochloride.
    Ryan JR; Jain AK; McMahon FG
    Clin Pharmacol Ther; 1975 Jan; 17(1):83-7. PubMed ID: 1091391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colestipol therapy of hyperlipidemia in man.
    Sachs BA; Wolfman L
    Proc Soc Exp Biol Med; 1974 Dec; 147(3):694-7. PubMed ID: 4445156
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent.
    Nye ER; Jackson D; Hunter JD
    N Z Med J; 1972 Jul; 76(482):12-6. PubMed ID: 4344110
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia.
    Miller NE; Clifton-Bligh P; Nestel PJ; Whyte HM
    Med J Aust; 1973 Jun; 1(25):1223-7. PubMed ID: 4579666
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in plasma lipoprotein lipids in hypercholesterolaemic patients treated with the bile acid-sequestering resin, colestipol.
    Clifton-Bligh P; Miller NE; Nestel PJ
    Clin Sci Mol Med; 1974 Dec; 47(6):547-57. PubMed ID: 4375013
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man.
    Miller NE; Clifton-Bligh P; Nestel PJ
    J Lab Clin Med; 1973 Dec; 82(6):876-90. PubMed ID: 4758739
    [No Abstract]   [Full Text] [Related]  

  • 9. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.
    Glueck CJ; Ford S; Scheel D; Steiner P
    JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased plasma cholesterol esterifying activity during Colestipol resin therapy in man.
    Clifton-Bligh P; Miller NE; Nestel PJ
    Metabolism; 1974 May; 23(5):437-44. PubMed ID: 4825300
    [No Abstract]   [Full Text] [Related]  

  • 11. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
    Harvengt C; Desager JP
    Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
    Grundy SM; Mok HY
    J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colestipol and clofibrate in hypercholesterolemia.
    Dujovne CA; Hurwitz A; Kauffman RE; Azarnoff DL
    Clin Pharmacol Ther; 1974 Aug; 16(2):291-6. PubMed ID: 4604239
    [No Abstract]   [Full Text] [Related]  

  • 14. Response of hyperlipoproteinemia to colestipol.
    Sachs BA; Wolfman L
    N Y State J Med; 1973 May; 73(9):1068-70. PubMed ID: 4512165
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
    Goodman DS; Noble RP; Dell RB
    J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
    Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G
    G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver scan in hyperlipoproteinemia.
    Sachs BA; Bardfeld PA; Bodian JE; Sugarman LA; Hellman L
    JAMA; 1974 Feb; 227(8):907-10. PubMed ID: 4590252
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of colestipol or cholestyramine on serum cholesterol and triglycerides in a long-term controlled study.
    Ryan JR; Jain A
    J Clin Pharmacol New Drugs; 1972 Jul; 12(7):268-73. PubMed ID: 4557535
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholesterol-lowering effect of colestipol hydrochloride given twice daily in hypercholesterolemic patients.
    Gundersen K; Cooper EE; Ruoff G; Nikolai T; Assenzo JR
    Atherosclerosis; 1976; 25(2-3):303-10. PubMed ID: 795441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colestipol by hypercholesteremia in diabetics].
    Düntsch G
    Fortschr Med; 1977 Jun; 95(22):1492-6. PubMed ID: 873435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.